Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Equity Investor 6 August

Julia Lee
August 7, 2018

Market Update

Julia Lee
August 2, 2018

Equity Investor

Julia Lee
July 31, 2018

Equity Investor

Julia Lee
July 24, 2018

Market Update

Julia Lee
July 23, 2018

10 favoured stocks

Bell Direct
July 17, 2018

Market Update

Julia Lee
June 21, 2018

Equity Investor 18 June

Julia Lee
June 19, 2018

Market Update

Julia Lee
June 7, 2018